MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TS-09-0008699
Astrel Genome Limited - healthcare in Patancheru, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹21.82 Lakh
▲ 792% YoY
Net loss · FY 2025
₹28.68 Lakh
Net margin -131.4%
EBITDA · FY 2025
-₹28.34 Lakh
EBITDA margin -129.9%
Authorised capital
₹15 Cr
Registered with MCA
Paid-up capital
₹11 Cr
Issued & subscribed
Company age
21 yrs
Est. 2005
Directors on board
5
As per MCA filings
Active GSTINs
1
GST registered
About Astrel Genome Limited
Data last updated:
Astrel Genome Limited is a public limited company based in Patancheru, Telangana, India. It operates in the alternative and holistic medicine segment of the healthcare sector. It was incorporated on 09 February 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2005PLC045301. Its GSTIN is 36AAFCA0647K1ZO (Telangana).
The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹11 Cr. It is led by directors including Sree Padma Yarlagadda (Managing Director) and Medasani Prasanna Lakshmi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Industrial Park, Patancheru, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹21.82 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹28.68 Lakh (net margin -131.4%) and EBITDA of -₹28.34 Lakh (EBITDA margin -129.9%). Revenue has grown at a compounded annual rate (CAGR) of 101% over three years and 18% over five years.
Court records list 1 case involving the company, including 1 filed by the company.
Astrel Genome Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0008699). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website astrel.in.
Company Details of Astrel Genome Limited
CIN U24230TG2005PLC045301
Registration Number 045301
Incorporation Date 09 February 2005
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-09-0008699
CIN History of Astrel Genome Limited
Astrel Genome has one previous CIN (Corporate Identification Number): U24230AP2005PLC045301. The current CIN is U24230TG2005PLC045301, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG2005PLC045301 | Current |
| U24230AP2005PLC045301 | Previous |
Key People
Sree Padma Yarlagadda Managing Director Medasani Prasanna Lakshmi Director Asha Polavarapu Director Recognitions & Rankings of Astrel Genome
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No.F26 Flo – Tsiic, Industrial Park Ameenpur, Patancheru, Telangana, India – 502319
- IndustryHealthcare, Alternative & Holistic Medicine
Comprehensive company report
Astrel Genome Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Astrel Genome Limited
The main business activity of Astrel Genome is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Astrel Genome Limited FY 2025 filings available
Astrel Genome Limited reported revenue of ₹21.82 Lakh (up 792% YoY) for FY 2025.
Revenue · FY 2025
₹21.82 Lakh ▲ 792%
Net loss · FY 2025
₹28.68 Lakh margin -131.4%
EBITDA · FY 2025
-₹28.34 Lakh margin -129.9%
Compounded Annual Growth Rate (CAGR) of Astrel Genome Limited
Revenue CAGR growth
1 year
▲ 792%
3 years · compounded
▲ 101%
5 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▼ 241%
3 years · compounded
▼ 18%
5 years · compounded
▲ 6%
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 792% growth in the latest year. EBITDA fell 241% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Astrel Genome Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹28.34 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹28.68 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Astrel Genome Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -129.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -131.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Astrel Genome are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Astrel Genome Limited
Astrel Genome has 5 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sree Padma Yarlagadda | Managing Director | 20 Jan 2011 | 15 Years 9 Months | Current |
| Medasani Prasanna Lakshmi | Director | 02 Oct 2018 | 8 Years 0 Months | Current |
| Asha Polavarapu | Director | 25 Feb 2013 | 13 Years 7 Months | Current |
| Munisekhar Medasani | Director | 09 Feb 2005 | 21 Years 8 Months | Current |
| Sanjeev Kumar Sethi | Additional Director | 15 Feb 2025 | 1 Years 8 Months | Current |
Peer Comparison of Astrel Genome Limited
Astrel Genome Limited is compared with the companies closest to it by revenue in the Healthcare industry (Alternative Medicine). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Travancore Ayurveda Private Limited | ₹44.29 Lakh (FY 2024) | •••• | •••• | -3.0% | •••• | Thiruvananthapuram, Kerala, India |
| Cadicare Pharmaceuticals Private Limited | ₹39.29 Lakh (FY 2024) | •••• | •••• | 4.0% | •••• | New Delhi, Delhi, India |
| Himalayan Healing Touch Private Limited | ₹37.71 Lakh (FY 2025) | •••• | •••• | -14.0% | •••• | Delhi, India |
| Surecure Clinic (OPC) Private Limited | ₹33.74 Lakh (FY 2025) | •••• | •••• | 19.0% | •••• | Mumbai, Maharashtra, India |
| Bacfo & Krauter Holdings Private Limited | ₹22.75 Lakh (FY 2024) | •••• | •••• | 1717.0% | •••• | New Delhi, Delhi, India |
| Astrel Genome Limited this company | ₹21.82 Lakh (FY 2025) | •••• | •••• | 792.0% | •••• | Patancheru, Telangana, India |
| Ayushmaanbhava Healing and Research Center Private Limited | ₹21.63 Lakh (FY 2020) | •••• | •••• | -37.0% | •••• | Indore, Madhya Pradesh, India |
| Medmall Digital Healthcare India Private Limited | ₹17.28 Lakh (FY 2025) | •••• | •••• | -24.0% | •••• | Delhi, India |
| Doctors Pharmaceuticals Private Limited | ₹13.03 Lakh (FY 2025) | •••• | •••• | -14.0% | •••• | Unnao, Uttar Pradesh, India |
| Hoogar Pharmaceuticals Private Limited | ₹12.56 Lakh (FY 2025) | •••• | •••• | 423.0% | •••• | Bangalore, Karnataka, India |
| Schwandt Ujagare Alternative Medicine Private Limited | ₹11.88 Lakh (FY 2025) | •••• | •••• | -3.0% | •••• | Thane, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Astrel Genome by revenue in the Healthcare industry (Alternative Medicine), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Astrel Genome Limited
Astrel Genome Limited is audited by P MURALI & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| P MURALI & CO | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Astrel Genome Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Astrel Genome Limited
Astrel Genome Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Astrel Genome Limited
Astrel Genome Limited has 1 court case on record: 1 filed by Astrel Genome. All case is disposed. Status as checked on 03 Oct 2026.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court for State of Telangana | Court case (CRLP) | Filed by the company against an individual | Disposed |
Premium access
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Astrel Genome Limited
Employment history and EPFO contributions of people linked to Astrel Genome.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Astrel Genome Limited
Astrel Genome Limited has 12 board changes on record since 2005: 5 appointments and 7 cessations. The latest: Sanjeev Kumar Sethi was appointed as Additional Director on 15 Feb 2025.
AGM
Astrel Genome Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Astrel Genome Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Sanjeev Kumar Sethi was appointed as Additional Director.
Ceased
Medasani Prasanna Lakshmi ceased to be Additional Director.
Appointed
Medasani Prasanna Lakshmi was appointed as Director.
Ceased
Vidavaluru Mohan Rao ceased to be Additional Director.
Ceased
Asha Polavarapu ceased to be Additional Director.
Appointed
Asha Polavarapu was appointed as Director.
Ceased
Prasannaanjaneya Reddy Lebaka ceased to be Director.
Ceased
Neelaveni Thummala ceased to be Director.
Ceased
Nageswararao Nimmagadda ceased to be Director.
Appointed
Sree Padma Yarlagadda was appointed as Managing Director.
3 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Astrel Genome Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Astrel Genome Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Astrel Genome Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Astrel Genome Limited
Astrel Genome has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCA0647K1ZO | Telangana | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Astrel Genome Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Astrel Genome Limited
Astrel Genome is an active public limited company based in Patancheru, Telangana, India. The company works in alternative and holistic medicine, within the healthcare industry. It was incorporated on 09 February 2005 (21+ years old) and is registered under CIN U24230TG2005PLC045301.
Astrel Genome reported revenue of ₹21.82 Lakh for FY 2025 (up 792% YoY).
Astrel Genome has 5 current directors:
- Sree Padma Yarlagadda - Managing Director
- Medasani Prasanna Lakshmi - Director
- Asha Polavarapu - Director
- Munisekhar Medasani - Director
- Sanjeev Kumar Sethi - Additional Director
Astrel Genome reported a net loss of ₹28.68 Lakh (net margin -131.4%) and EBITDA of -₹28.34 Lakh (EBITDA margin -129.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Astrel Genome is 101% over three years and 18% over five years. In the latest year (FY 2025) revenue rose 792%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Astrel Genome is 36AAFCA0647K1ZO, registered in Telangana.
The CIN (Corporate Identification Number) of Astrel Genome is U24230TG2005PLC045301. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Astrel Genome has 1 court case on record: 1 filed by the company.
Astrel Genome was incorporated on 09 February 2005, making it 21+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Astrel Genome by revenue are Travancore Ayurveda Private Limited, Cadicare Pharmaceuticals Private Limited, Himalayan Healing Touch Private Limited, Surecure Clinic (OPC) Private Limited, Bacfo & Krauter Holdings Private Limited and 5 more, all in the Healthcare industry (Alternative Medicine).
Sanjeev Kumar Sethi was appointed as Additional Director on 15 Feb 2025. Medasani Prasanna Lakshmi ceased to be Additional Director on 30 Sep 2019. Medasani Prasanna Lakshmi was appointed as Director on 02 Oct 2018. Astrel Genome has 12 board changes on record in total.